drug conjugated Surrobody program (i2 Pharmaceuticals)

N/A

Report date: 2025/01/26 17:59:34

Base Information

Drug Namedrug conjugated Surrobody program (i2 Pharmaceuticals)
Drug Alias Namedrug conjugated Surrobody program (Sea Lane Biotechnologies)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSea Lane Biotechnologies LLC
China Registration ClassN/A

Develop Information

Active Companiesi2 Pharmaceuticals Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A